Last reviewed · How we verify
DOPAMINE HYDROCHLORIDE
DOPAMINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 1974) for Improving hemodynamic status in distributive shock, Improving hemodynamic status in shock due to reduced cardiac output.
Dopamine Hydrochloride is a marketed drug primarily indicated for improving hemodynamic status in distributive shock. Its key strength lies in its established use and the protection of its key composition patent, which expires in 2028. The primary risk is the potential increase in competition as the patent expiration approaches.
At a glance
| Generic name | DOPAMINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1974 |
Approved indications
- Improving hemodynamic status in distributive shock
- Improving hemodynamic status in shock due to reduced cardiac output
Common side effects
Drug interactions
- Halogenated Anesthetics
- MAO Inhibitors
- Tricyclic Antidepressants
- Vasopressors
Key clinical trials
- Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms (NA)
- Clinical Laboratory Evaluation of Chronic Autonomic Failure
- PET Scanning in Parkinson s Disease
- Diagnosis of Pheochromocytoma (PHASE1)
- Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms (PHASE2)
- Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol (PHASE3)
- Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation (NA)
- Does Caffeine Facilitate Human Reward Learning Behaviors? (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DOPAMINE HYDROCHLORIDE CI brief — competitive landscape report
- DOPAMINE HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about DOPAMINE HYDROCHLORIDE
What is DOPAMINE HYDROCHLORIDE?
What is DOPAMINE HYDROCHLORIDE used for?
When was DOPAMINE HYDROCHLORIDE approved?
What development phase is DOPAMINE HYDROCHLORIDE in?
Related
- Indication: Drugs for Improving hemodynamic status in distributive shock
- Indication: Drugs for Improving hemodynamic status in shock due to reduced cardiac output
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing